Ulcers and Gastritis

This article reviews recently published literature regarding ulcers and gastritis. Although endoscopy is the most useful procedure for diagnosis in the upper gastrointestinal tract, complications do occur, and procedure-related costs are significant. The appropriate indication for endoscopy has recently been debated. Helicobacter pylori is known to be an important pathogen involved in gastric and duodenal inflammation. Peptic ulcer disease and severe gastric mucosal injury are caused by virulent strains, and many reports have focused on CagA. Follow-up studies on surveillance endoscopy in patients with peptic ulcer or gastritis report that patients with atrophic gastritis and intestinal metaplasia are at significantly higher risk for gastric cancer. H. pylori eradication sometimes causes gastroduodenal erosion and reflux esophagitis, and the mechanisms involved have been revealed. Proton-pump inhibitors are useful in the treatment of ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs), reflux esophagitis, and for preventing rebleeding after endoscopic hemostasis, but the effect of long-term acid suppression on the gastric mucosa is still a matter of debate. H. pylori infection and NSAID intake are both risk factors for peptic ulcer disease, and are important aspects in this field.

References

• 1 Tytgat G N. Role of endoscopy and biopsy in the work up of dyspepsia.  Gut. 2002;  50 (Suppl. 4) 13-16
• 2 Trevisani L, Sartori S, Gilli G. et al . Appropriateness of upper gastrointestinal endoscopy: a hospital-based study.  Dig Dis Sci. 2001;  46 2695-2699
• 3 Manes G, Balzano A, Marone P. et al . Appropriateness and diagnostic yield of upper gastrointestinal endoscopy in an open-access endoscopy system: a prospective observational study based on the Maastricht guidelines.  Aliment Pharmacol Ther. 2002;  16 105-110
• 4 McColl K E, Murray L S, Gillen D. et al . Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia.  Br Med J. 2002;  324 999-1002
• 5 Mardh E, Mardh S, Mardh B. et al . Diagnosis of gastritis by means of a combination of serological analyses.  Clin Chim Acta. 2002;  320 17-27
• 6 Yagi K, Nakamura A, Sekine A. Characteristic endoscopic and magnified endoscopic findings in the normal stomach without Helicobacter pylori infection.  J Gastroenterol Hepatol. 2002;  17 39-45
• 7 Yagi K, Nakamura A, Sekine A. Comparison between magnifying endoscopy and histological, culture and urease test findings from the gastric mucosa of the corpus.  Endoscopy. 2002;  34 376-381
• 8 Jung H K, Lee K E, Chu S H. et al . Reactive oxygen species activity, mucosal lipoperoxidation and glutathione in Helicobacter pylori-infected gastric mucosa.  J Gastroenterol Hepatol. 2001;  16 1336-1340
• 9 Noguchi K, Kato K, Moriya T. et al . Analysis of cell damage in Helicobacter pylori-associated gastritis.  Pathol Int. 2002;  52 110-118
• 10 Saruc M, Demir M A, Kucukmetin N. et al . Histological and clinical predictive value of determination of tissue CagA status by PCR in Helicobacter pylori infected patients; results of the large population based study in western Turkey.  Hepatogastroenterology. 2002;  49 878-881
• 11 Palli D, Menegatti M, Masala G. et al . Helicobacter pylori infection, anti-cagA antibodies and peptic ulcer: a case-control study in Italy.  Aliment Pharmacol Ther. 2002;  16 1015-1020
• 12 Arents N L, van Zwet A A, Thijs J C. et al . The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease.  Am J Gastroenterol. 2001;  96 2603-2608
• 13 Whiting J L, Sigurdsson A, Rowlands D C. et al . The long-term results of endoscopic surveillance of premalignant gastric lesions.  Gut. 2002;  50 378-381
• 14 Uemura N, Okamoto S, Yamamoto S. et al . Helicobacter pylori infection and the development of gastric cancer.  N Engl J Med. 2001;  345 784-789
• 15 The Eurohepygast Study Group. Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study.  Gut. 2002;  50 779-785
• 16 Sakaki N, Kozawa H, Egawa N. et al . Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings.  Aliment Pharmacol Ther. 2002;  16 (Suppl. 2) 198-203
• 17 Asaka M, Sugiyama T, Nobuta A. et al . Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study.  Helicobacter. 2001;  6 294-299
• 18 Lanzafame S, Torrisi A, Favara C. et al . Correlation between intestinal metaplasia of the gastric cardia and gastroesophageal reflux disease.  Hepatogastroenterology. 2001;  48 1007-1010
• 19 Goldblum J R, Richter J E, Vaezi M. et al . Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.  Am J Gastroenterol. 2002;  97 302-311
• 20 Morini S, Zullo A, Hassan C. et al . Gastric cardia inflammation: role of Helicobacter pylori infection and symptoms of gastroesophageal reflux disease.  Am J Gastroenterol. 2001;  96 2337-2340
• 21 Wolf C, Seldenrijk C A, Timmer R. et al . Does carditis have two different etiologies?.  Dig Dis Sci. 2001;  46 2424-2432
• 22 Malfertheiner P, Megraud F, O’Morain C. et al . Current concepts in the management of Helicobacter pylori infection: the Maastricht 2 - 2000 consensus report.  Aliment Pharmacol Ther. 2002;  16 167-180
• 23 Miyake K, Tsukui T, Futagami S. et al . Effect of acid suppression therapy on development of gastric erosions after cure of Helicobacter pylori infection.  Aliment Pharmacol Ther. 2002;  16 (Suppl. 2) 210-216
• 24 Shiotani A, Nishioka S, Iguchi M. et al . Duodenal erosions after eradication of Helicobacter pylori infection.  Gastrointest Endosc. 2001;  54 448-453
• 25 Rokkas T, Ladas S D, Triantafyllou K. et al . The association between CagA status and the development of esophagitis after the eradication of Helicobacter pylori. .  Am J Med. 2001;  110 703-707
• 26 Suzuki M, Suzuki H, Kitahora T. et al . Treatment with a proton-pump inhibitor promotes corpus gastritis in patients with Helicobacter pylori-infected antrum-predominant gastritis.  Aliment Pharmacol Ther. 2002;  16 159-165
• 27 van Grieken N C, Meijer G A, Weiss M M. et al . Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study.  Am J Gastroenterol. 2001;  96 2882-2886
• 28 Sanduleanu S, de Bruine A, Stridsberg M. et al . Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.  Eur J Clin Invest. 2001;  31 802-811
• 29 van Leerdam M E, Tytgat G N. Helicobacter pylori infection in peptic ulcer haemorrhage.  Aliment Pharmacol Ther. 2002;  16 (Suppl. 1) 66-78
• 30 Frezza M, Gorji N, Melato M. The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events.  J Clin Pathol. 2001;  54 521-525
• 31 Feldman M, Cryer B, Mallat D. et al . Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.  Am J Gastroenterol. 2001;  96 1751-1757
• 32 Voutilainen M, Mantynen T, Farkkila M. et al . Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.  Scand J Gastroenterol. 2001;  36 817-821
• 33 Huang J Q, Sridhar S, Hunt R H. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.  Lancet. 2002;  359 14-22
• 34 Gisbert J P, Gonzalez L, de Pedro A. et al . Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.  Scand J Gastroenterol. 2001;  36 717-724
• 35 Xia H H, Wong B C, Wong K W. et al . Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study.  Aliment Pharmacol Ther. 2001;  15 1875-1882
• 36 Chan F K, To K F, Wu J C. et al . Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.  Lancet. 2002;  359 9-13
• 37 Hawkey C J, Laine L, Harper S E. et al . Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials.  Aliment Pharmacol Ther. 2001;  15 1593-1601
• 38 Graham D Y, Agrawal N M, Campbell D R. et al . Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs. lansoprazole.  Arch Intern Med. 2002;  162 169-175
• 39 Javid G, Masoodi I, Zargar S A. et al . Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer.  Am J Med. 2001;  111 280-284
• 40 Sheu B S, Chi C H, Huang C C. et al . Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding.  Aliment Pharmacol Ther. 2002;  16 137-143
• 41 Annibale B, Capurso G, Chistolini A. et al . Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms.  Am J Med. 2001;  111 439-445
• 42 Capurso G, Lahner E, Marcheggiano A. et al . Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anaemia associated with Helicobacter pylori infection.  Aliment Pharmacol Ther. 2001;  15 1753-1761
• 43 Siu W T, Leong H T, Law B K. et al . Laparoscopic repair for perforated peptic ulcer: a randomized controlled trial.  Ann Surg. 2002;  235 313-319
• 44 Kumar D, Sinha A N. Helicobacter pylori infection delays ulcer healing in patients operated on for perforated duodenal ulcer.  Indian J Gastroenterol. 2002;  21 19-22